CurveBeam AIASX:CVB -3.57% PB Ratio is 0.35 as of Jun. 25, 2026, which is 61% below its 10-year median of 0.89. The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, CurveBeam AI ranks better than 96.07% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), CurveBeam AI's share price is A$0.027. CurveBeam AI's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.08. Hence, CurveBeam AI's PB Ratio of today is 0.35.
The historical rank and industry rank for CurveBeam AI's PB Ratio or its related term are showing as below:
ASX:CVB'
s PB Ratio Range Over the Past 10 Years
Min: 0.35 Med: 0.89 Max: 2.01
Current: 0.35
During the past 5 years, CurveBeam AI's highest PB Ratio was 2.01. The lowest was 0.35. And the median was 0.89.
ASX:CVB's PB Ratio is ranked better than 96.07% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs ASX:CVB: 0.35
During the past 12 months, CurveBeam AI's average Book Value Per Share Growth Rate was -26.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
CurveBeam AI PB Ratio Related Terms
CurveBeam AI PB Ratio Historical Data
* Premium members only.
The historical data trend for CurveBeam AI's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CurveBeam AI's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CurveBeam AI PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's PB Ratio distribution charts can be found below:
* The bar in red indicates where CurveBeam AI's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
CurveBeam AI's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
CurveBeam AI (ASX:CVB) has a PB Ratio of 0.35 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on CurveBeam AI and its competitors. This is 61% below median its historical median of 0.89. Over the past decade, CurveBeam AI's PB Ratio has ranged from 0.35 to 2.01. According to the industry distribution chart, CurveBeam AI ranks #31 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 3.9%.
Is CurveBeam AI's PB Ratio too high?
CurveBeam AI's current PB Ratio of 0.35 is 61% below median its 10-year median of 0.89. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 2.01. The Medical Devices & Instruments industry median PB Ratio is 2.05. CurveBeam AI's value of 0.35 is 82.9% below this industry median. Based on the distribution chart, CurveBeam AI ranks #31 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does CurveBeam AI's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CurveBeam AI ranks #31 out of 788 companies for PB Ratio. This places CurveBeam AI in the top 4% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.05. CurveBeam AI's value of 0.35 is 82.9% below this benchmark. Historically, CurveBeam AI's own PB Ratio has ranged from 0.35 to 2.01 over the past decade. While the company's 10-year median is 0.89 vs. the industry median of 2.05, CurveBeam AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CurveBeam AI's current PB Ratio of 0.35 is 82.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on CurveBeam AI and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CurveBeam AI's current PB Ratio is 0.35, which is 61% below median its own 10-year median of 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current PB Ratio of 0.35. The current PB Ratio is 0.35, which is 61% below median its 10-year median of 0.89 and 82.9% below the Medical Devices & Instruments industry median of 2.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current PB Ratio is 0.35 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CVB has been successfully added to your 